Semaglutide, more commonly known as Ozempic, can do more than help with weight loss. A new clinical trial shows it helps ...

Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...

Hydreight Technologies Inc. ("Hydreight"or the "Company") , a fast-growing mobile clinical network and medical platform which enables flexible at-home medical services across 50 states in the United ...

For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy (NAION).

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

The rate of emergency department visits for adverse events among patients dispensed semaglutide is low, with most visits involving gastrointestinal effects, according to a research letter published ...

from the US Centers for Disease Control and Prevention in Atlanta, and colleagues characterized and quantified US emergency department visits that clinicians attributed to semaglutide adverse ...

53. Semler Scientific has offered to pay the Department of Justice nearly $30 million to settle federal health care fraud claims related to its peripheral artery disease test, QuantaFlo — a ...

In the absence of proximal atherosclerotic disease, unilateral vertebral artery stenosis or occlusion is well tolerated. Another indication for vertebral artery reconstruction pertains to patients ...